-
-
Call more information
660-596-2224 -
Hospitals have found a way to save money by using technology and new medical techniques to cut down on pricey blood transfusions, but it has come at the expense of thousands of jobs in the blood banking sector, the New York Times reports. Even as the population ages and traditionally requires more blood during surgeries, […]
Read MoreCombination hydrocodone products, currently considered Schedule III drugs, will be reclassified as Schedule II because of their high risk for abuse. The new regulation from the Drug Enforcement Administration will take effect in 45 days. “Schedule II drugs … are defined as drugs with a high potential for abuse, less abuse potential than Schedule I […]
Read MoreThis is for our readers who treat pain patients. Chronic pain is a difficult development area for both drug and device developers; creating a product that effectively reduces pain and is sufficiently tolerable over long periods remains a challenge. Now sufferers with temporomandibular joint (TMJ) disorder pain have a new device option that has proven […]
Read MoreI thought this was a study anesthesia providers would like knowing about since endo is the number one reason for a patient to receive an anesthetic. Older patients were 28% more likely than younger ones to be hospitalized for treatment of complications following a surveillance colonoscopy, study data shows. Follow-up colonoscopies for people over age […]
Read MoreMI ‘signal’ seen with one drug, but not others Experts said they hoped a recent FDA advisory panel recommendation against requiring randomized controlled cardiovascular outcomes trials for new drugs to treat constipation associated with use of opioids would unblock the field for more such medications. Opioid-induced constipation (OIC) “is a real problem,” said Eugene Viscusi, […]
Read More